-
1Academic Journal
المؤلفون: Tausch, E., Bahlo, J., Robrecht, S., Schneider, C., Bloehdorn, J., Schrell, S., Galler, C., Al‐Sawaf, O., Fink, A.‐M., Eichhorst, B., Kreuzer, K.‐A., Tandon, M., Humphrey, K., Jiang, Y., Schary, W., Porro Lurà, M., Döhner, H., Fischer, K., Hallek, M., Stilgenbauer, S.
المصدر: HemaSphere ; volume 3, issue S1, page 4 ; ISSN 2572-9241 2572-9241
-
2Academic Journal
المؤلفون: Greil, R., Fraser, G., Leber, B., Marks, R., Quaresmini, G., Middeke, J. Moritz, Semenzato, G., Schary, W., Boyer, M., Breuleux, M., Crompton, N., Humphrey, K., Marlton, P.
المصدر: HemaSphere ; volume 3, issue S1, page 527 ; ISSN 2572-9241 2572-9241
-
3Academic Journal
المؤلفون: Tausch, E., Schneider, C., Robrecht, S., Zhang, C., Dolnik, A., Bloehdorn, J., Bahlo, J., Al-Sawaf, O., Ritgen, M., Fink, A.M., Eichhorst, B., Kreuzer, K.A., Tandon, M., Humphrey, K., Jiang, Y., Schary, W., Bullinger, L., Mertens, D., Lurà, M.P., Kneba, M., Döhner, H., Fischer, K., Hallek, M., Stilgenbauer, S.
مصطلحات موضوعية: Cancer Research
Relation: Prognostic and predictive impact of genetic markers in patients with CLL treated with obinutuzumab and venetoclax. Tausch, E. and Schneider, C. and Robrecht, S. and Zhang, C. and Dolnik, A. and Bloehdorn, J. and Bahlo, J. and Al-Sawaf, O. and Ritgen, M. and Fink, A.M. and Eichhorst, B. and Kreuzer, K.A. and Tandon, M. and Humphrey, K. and Jiang, Y. and Schary, W. and Bullinger, L. and Mertens, D. and Lurà, M.P. and Kneba, M. and Döhner, H. and Fischer, K. and Hallek, M. and Stilgenbauer, S. Blood 135 (26): 2402-2412. 25 June 2020
-
4Electronic Resource
المؤلفون: Liberati A.M., Fogliatto L.M., Niemann C.U., Weinkove R., Robinson S., Kipps T.J., Tausch E., Schary W., Ritgen M., Wendtner C.-M., Kreuzer K.-A., Eichhorst B., Stilgenbauer S., Hallek M., Fischer K., Le Du K., Pinilla-Ibarz J., Zhang C., Tandon M., Sinha A., Fink A.-M., Robrecht S., Samoylova O., Sivcheva L., Opat S., Al-Sawaf O.
مصطلحات الفهرس: infusion related reaction/si [Side Effect], intention to treat analysis, leukocyte count, leukopenia/si [Side Effect], longitudinal study, lymphocytopenia/si [Side Effect], major clinical study, male, multicenter study, multiple cycle treatment, nausea/si [Side Effect], neutropenia/si [Side Effect], neutrophil count, open study, overall survival, platelet count, pneumonia/si [Side Effect], priority journal, progression free survival, randomized controlled trial, sepsis/si [Side Effect], septic shock/si [Side Effect], side effect/si [Side Effect], thrombocytopenia/si [Side Effect], treatment duration, treatment outcome, treatment response, treatment withdrawal, tumor lysis syndrome/si [Side Effect], vertigo/si [Side Effect], alanine aminotransferase/ec [Endogenous Compound], aspartate aminotransferase/ec [Endogenous Compound], chlorambucil/ae [Adverse Drug Reaction], chlorambucil/ct [Clinical Trial], chlorambucil/cb [Drug Combination], chlorambucil/cm [Drug Comparison], chlorambucil/dt [Drug Therapy], chlorambucil/po [Oral Drug Administration], liver enzyme/ec [Endogenous Compound], obinutuzumab/ae [Adverse Drug Reaction], obinutuzumab/ct [Clinical Trial], obinutuzumab/cb [Drug Combination], obinutuzumab/cm [Drug Comparison], obinutuzumab/dt [Drug Therapy], obinutuzumab/iv [Intravenous Drug Administration], venetoclax/ae [Adverse Drug Reaction], venetoclax/ct [Clinical Trial], venetoclax/cb [Drug Combination], venetoclax/cm [Drug Comparison], venetoclax/dt [Drug Therapy], venetoclax/po [Oral Drug Administration], life expectancy, acute heart infarction/si [Side Effect], adult, aged, alanine aminotransferase blood level, anemia/si [Side Effect], article, aspartate aminotransferase blood level, asthenia/si [Side Effect], atrial fibrillation/si [Side Effect], basal cell carcinoma/si [Side Effect], chronic lymphatic leukemia/dt [Drug Therapy], clinical effectiveness, constipation/si [Side Effect], controlled study, coughing/si [Side Effect], creatinine clearance, cytokine release syndrome/si [Side Effect], diarrhea/si [Side Effect], drug safety, drug tolerability, dyspnea/si [Side Effect], exploratory research, faintness/si [Side Effect], fatigue/si [Side Effect], febrile neutropenia/si [Side Effect], female, fever/si [Side Effect], follow up, geographic distribution, granulocytopenia/si [Side Effect], headache/si [Side Effect], heart failure/si [Side Effect], heart infarction/si [Side Effect], human, hyperglycemia/si [Side Effect], hypertension/si [Side Effect], hyperuricemia/si [Side Effect], hypotension/si [Side Effect], Article
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/29065
The Lancet Oncology
Click here for full text options
LibKey Link -
5Electronic Resource
المؤلفون: Al-Sawaf O., Zhang C., Tandon M., Sinha A., Niemann C.U., Weinkove R., Robinson S., Kipps T., Tausch E., Schary W., Ritgen M., Wendtner C., Kreuzer K., Eichhorst B., Stilgenbauer S., Hallek M., Fischer K., Fink A., Robrecht S., Samoylova O., Liberati A.M., Pinilla J., Opat S., Sivcheva L., Le Du K., Fogliatto L.M.
مصطلحات الفهرس: drug efficacy, adult, cancer patient, cancer survival, chronic lymphatic leukemia, clinical trial, conference abstract, controlled study, drug combination, drug safety, drug therapy, female, follow up, gene deletion, high risk population, high throughput sequencing, human, major clinical study, male, minimal residual disease, multicenter study, overall survival, pharmacokinetics, phase 3 clinical trial, progression free survival, randomized controlled trial, remission, risk assessment, second cancer, chlorambucil, endogenous compound, obinutuzumab, protein p53, venetoclax, Conference Abstract
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/35095
Click here for full text options
LibKey Link -
6Academic Journal
المؤلفون: Fischer, K, Ritgen, M, Al-Sawaf, O, Robrecht, S, Tandon, M, Fink, A M, Schilhabel, A, Stübig, T, Brüggemann, M, Jiang, Y, Schary, W, Eichhorst, BF, Wendtner, CM, Tausch, E, Kreuzer, KA, Langerak, Ton, Goede, V, Böttcher, S, Stilgenbauer, S, Kneba, M, Hallek, M
المصدر: Fischer , K , Ritgen , M , Al-Sawaf , O , Robrecht , S , Tandon , M , Fink , A M , Schilhabel , A , Stübig , T , Brüggemann , M , Jiang , Y , Schary , W , Eichhorst , BF , Wendtner , CM , Tausch , E , Kreuzer , KA , Langerak , T , Goede , V , Böttcher , S , Stilgenbauer , S , Kneba , M & Hallek , M 2019 , ' Quantitative Analysis of Minimal Residual Disease (MRD) Shows High Rates of Undetectable ....
مصطلحات موضوعية: /dk/atira/pure/keywords/researchprograms/AFL001000/EMCOR01, name=EMC OR-01
-
7Academic Journal
المؤلفون: Al‐Sawaf, O., Lilienweiss, E., Bahlo, J., Robrecht, S., Fink, A., Patz, M., Tandon, M., Humphrey, K., Jiang, Y., Schary, W., Porro Lurà, M., Ritgen, M., Tausch, E., Stilgenbauer, S., Eichhorst, B., Fischer, K., Hallek, M., Kreuzer, K.
المصدر: Hematological Oncology ; volume 37, issue S2, page 104-106 ; ISSN 0278-0232 1099-1069
-
8Academic Journal
المؤلفون: Tausch, E., Bahlo, J., Robrecht, S., Schneider, C., Bloehdorn, J., Schrell, S., Galler, C., Al‐Sawaf, O., Fink, A., Eichhorst, B., Kreuzer, K., Tandon, M., Humphrey, K., Jiang, Y., Schary, W., Porro Lurà, M., Döhner, H., Fischer, K., Hallek, M., Stilgenbauer, S.
المصدر: Hematological Oncology ; volume 37, issue S2, page 84-86 ; ISSN 0278-0232 1099-1069
-
9Academic JournalThe pharmacokinetics of intravenous, intramuscular, and subcutaneous nalbuphine in healthy subjects.
المؤلفون: Lo, M., Lee, F., Schary, W., Whitney, C.
المصدر: European Journal of Clinical Pharmacology; 1987, Vol. 33 Issue 3, p297-301, 5p
-
10Academic Journal
المؤلفون: Howrie, D., Pieniaszek, H., Fogoros, R., Juhl, R., Schary, W., Whitney, C., Dittert, L.
المصدر: European Journal of Clinical Pharmacology; 1987, Vol. 32 Issue 6, p607-610, 4p
-
11Academic Journal
المؤلفون: Francisco, G. E., Honigberg, I. L., Stewart, J. T., Kotzan, J. A., Brown, W. J., Schary, W. L., Pelsor, F. R., Shah, V. P.
المصدر: Biopharmaceutics & Drug Disposition; 1984, Vol. 5 Issue 4, p335-344, 10p
-
12Academic Journal
المؤلفون: Aarons, L J, Schary, W L, Rowland, M
المصدر: Journal of Pharmacy and Pharmacology ; volume 29, issue Supplement_1, page 2P-2P ; ISSN 2042-7158 0022-3573
مصطلحات موضوعية: Pharmaceutical Science, Pharmacology